Beta

Beta. We're still building this. Tell us

CognitiveInjectable

Cerebrolysin

A pig-brain extract given in daily courses after a stroke or head injury. Decades of use abroad, mixed trials, not a nootropic.

UnderstandWhat it isApplyHow to use it

What it is

Cerebrolysin is for people rebuilding after something hit the brain: a stroke, a concussion that will not clear, or a parent whose memory is sliding. It is a ready-made liquid given as a daily course for two to three weeks, and the honest expectation is a modest, gradual lift in recovery, not a sharper brain on a healthy day.

Who uses it: stroke patients in the rehab window, people with lingering post-concussion fog, families dealing with vascular dementia, and a smaller group of biohackers who run a course for 'neuroplasticity'. The first three groups are what the research is about. The last group is paying for a drug designed for injured brains and should read the evidence paragraph below before buying ten ampoules.

What it is, plainly: not a peptide but a soup of small peptides and amino acids extracted from pig brain, standardized to about 215 mg per mL, sold as sealed liquid ampoules. The idea is that the fragments mimic the brain's own growth factors (BDNF, NGF) and help damaged neurons survive and rewire. Because it is a mixture there is no single receptor or half-life, and it only works injected; swallowed, the stomach digests it.

The timeline and how it is run: a course is once a day for 10 to 20 days. Up to about 5 mL goes intramuscular; the 10 and 30 mL doses are diluted and dripped in slowly over 20 to 60 minutes, which is a clinic procedure, not something for a kitchen table. People in rehab report the change toward the end of the course and in the weeks after, as slightly faster progress in therapy, better word-finding, less fatigue. A 10-day course at 10 mL is ten 10 mL ampoules; a 20-day course is twenty. The benefit is meant to outlast the course, so there is nothing to gain from running it straight through: repeat when the gains fade, anywhere from a few weeks to a few months later, and a few times a year at most. The common mistake is pushing a 10 mL dose by syringe in a minute: fast delivery is what causes the dizziness and hot flush.

The evidence, once: it is prescribed in more than 50 countries and has been studied for decades, and the result is genuinely mixed. The best systematic reviews found no clear benefit in acute stroke. Some traumatic brain injury rehab studies (the CAPTAIN trials) and a few vascular dementia trials show modest gains. Nothing has been replicated to the standard a US approval would need. So: plausible for recovery after injury, weak for a healthy brain.

When it is not worth it: if your brain is fine and you want focus, this is the wrong tool and a lot of money; Semax gives a same-day lift and costs a fraction. If you have a real neurological event, the course belongs inside a rehab plan with a doctor who knows you are on it, not instead of one. Cortexin is the powdered sibling with a similar story and less Western data.

Best known for
Recovery after stroke, head injury and vascular dementia
How it's taken
Daily for 10 to 20 days; up to 5 mL intramuscular, larger doses by slow IV drip
How fast
Changes show late in the course and over the following weeks
How long a cycle
10 to 20 days per course. A few weeks to a few months before the next course
Pairs with
Rehab, sleep and training; Semax for a daily nootropic layer

What people use it for

Stroke recovery

Some evidence

This is the most-studied use, with dozens of trials in Europe and Asia. The highest-quality systematic reviews found no clear benefit on survival in acute stroke (none of the trials measured disability), while some individual trials report better motor recovery in rehab. In practice that means it is a reasonable add-on inside a rehab program, not a rescue treatment.

Head injury and concussion that will not clear

Some evidence

The CAPTAIN trials in moderate to severe traumatic brain injury reported modest gains in function and thinking over placebo when it was given early and in repeated courses. The effects were small and the trials were sponsor-run, so read it as a reasonable bet for someone already in TBI rehab, not a cure for lingering fog.

Memory loss from poor blood flow

Early days

A few placebo-controlled trials in vascular dementia found small cognitive improvements over several months of courses. The signal is there but inconsistent, and nothing has shown it slows the disease. Families usually report that the person is a bit brighter during a course, then drifts back.

Sharper thinking in a healthy brain

Early days

There is no trial of Cerebrolysin in healthy people, and the biology (growth-factor support for damaged neurons) does not predict much for an undamaged brain. User reports of 'clarity' after a course are real but cannot be separated from the ritual of daily injections for three weeks. If that is your goal, spend the money elsewhere.

How people use it

RouteSlow IV
How oftenOnce a day
How long10 to 20 days per course
Ready to use it?Dosing and reconstitution guide
+ Track this peptide

Safety, in brief

Things people sometimes notice

  • Dizziness or a warm flush during and just after a dose, almost always from giving it too fast
  • Feeling wired or a little foggy on higher doses, which settles with a slower drip or a smaller dose
  • Soreness at an intramuscular site, since 5 mL is a large injection

The full picture — stop signs and who should talk to a doctor first — is on the dosing guide.

Sources

The labels and studies behind this page. Each link opens the original on PubMed, DailyMed or ClinicalTrials.gov.

  1. Cerebrolysin for acute ischaemic strokeZiganshina et al., Cochrane Database Syst Rev 2023 · Review
  2. Safety and efficacy of Cerebrolysin in motor function recovery after stroke: a meta-analysis of the CARS trialsGuekht et al., Neurol Sci 2017 · Review
  3. Cerebrolysin after moderate to severe traumatic brain injury: prospective meta-analysis of the CAPTAIN trial seriesVester et al., Neurol Sci 2021 · Review
  4. Cerebrolysin for vascular dementiaCui et al., Cochrane Database Syst Rev 2019 · Review
This is education, not medical advice. Peptides affect everyone differently. Please talk with a doctor before starting anything, especially if you take other medicines or have a health condition.
© 2026 PeptideHelp. This platform is for educational purposes only.
Cerebrolysin: what it does, research & side effects